Qiagen NV: Corporate and Strategic Assessment Report – Company Strategy, SWOT Analysis and 5-year Adjusted Financials with In-depth Company Profile

Qiagen, a Netherlands holding company, is one of the leading providers of technologies and products for pre-analytical sample preparation and linked molecular assay solutions. The company has a portfolio of over 500 proprietary, consumable products and automated solutions for sample collection, and nucleic acid and protein handling, separation, and purification.

Report Highlights
Qiagen's comprehensive product portfolio is categorized under the groups of consumables, instrumentation and other. The company markets its products in more than 40 countries across the world.

During 2002-2006, Qiagen's revenues grew at a CAGR of 12%, from $299 million to $466 million, which was primarily attributable to increased sales of the company's consumable products. The company generated 100% of its revenues from product sales during the historical period.

The company's product sales are expected to increase at a significant CAGR of 27% to reach $1,205 million by 2010 from $466 million in 2006. This represents an absolute total revenue growth of +$740 million during 2006-2010.
[Studien Infos ausblenden]

Overview 1
Catalyst 1
Summary 1
Company Structure 6
Company Overview and Key Facts 6
Business Description 7
History 8
Locations and Subsidiaries 11
Company Financials 13
Stock Market Performance 13
P&L 14
Balance Sheet 17
Cash Flow 17
Geographic Segment Performance 18
Products & Services 20
AC Forecast Product Sales 21
Competitors and Strategic Business Relationships 22
Key Competitors 22
Key Clients 23
Shareholding Structure 24
Strategy 25
Company View 25
Corporate Strategy 28
SWOT Analysis 29
Overview 29
Strengths 30
Weaknesses 31
Opportunities 32
Threats 33
Value Chain Analysis 34
Overview 34
Discovery and Product Development 35
Manufacturing 35
Sales 35
Key Employees 36
List of Key Employees 36
Key Employee Biographies 37
Financial and Operational Overview 44
Financial and Operational Overview 44
APPENDIX 46
Ask the analyst 46
Datamonitor consulting 46
Disclaimer 46
[Inhaltsverzeichnis ausblenden]

Table 1: Qiagen- Key Facts 6
Table 2: Qiagen– Locations and Subsidiaries 11
Table 3: Qiagen- Year-End Share Price and Market Capitalization, 2002-2006 ($) 13
Table 4: Qiagen- Key Events Impacting Share Price Performance 13
Table 5: Qiagen- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 14
Table 6: Qiagen- Operating Cost Ratio Analysis, 2002-2006 (% of total revenues) 16
Table 7: Qiagen- Balance Sheet, 2002-2006 ($ Mn) 17
Table 8: Qiagen- Cash Flow, 2002-2006 ($ Mn) 17
Table 9: Qiagen- Geographic Breakdown, 2002-2006 ($ Mn) 18
Table 10: Qiagen- Products & Services 20
Table 11: Qiagen- Key Strategic Revenues, 2006-2010 ($ Mn) 21
Table 12: Qiagen- Key Competitors 22
Table 13: Qiagen- Key Clients 23
Table 14: Qiagen- Key Shareholders 24
Table 15: Qiagen- SWOT Analysis Summary 29
Table 16: Qiagen– Value Chain Analysis 34
Table 17: Qiagen- Key Employees 36
Table 18: Qiagen- Financial and Operational Overview 44
Figure 1: Qiagen- Operating Revenue/Cost Analysis, 2002-2006 ($ Mn) 15
[Tabellenverzeichnis ausblenden]